BMS 213 (Daklinza 30 mg)

Generic Name: daclatasvir

Pill imprint BMS 213 has been identified as Daklinza 30 mg.

Daklinza is used in the treatment of hepatitis c and belongs to the drug class NS5A inhibitors. Daklinza 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Daklinza

Generic Name:

daclatasvir

Imprint:

BMS 213

Strength:

30 mg

Color:

Green

Shape:

Five-sided

Availability:

Prescription only

Drug Class:

NS5A inhibitors

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb Company

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.